These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17626164)

  • 1. Endocytic down-regulation of ErbB2 is stimulated by cleavage of its C-terminus.
    Lerdrup M; Bruun S; Grandal MV; Roepstorff K; Kristensen MM; Hommelgaard AM; van Deurs B
    Mol Biol Cell; 2007 Sep; 18(9):3656-66. PubMed ID: 17626164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preubiquitinated chimeric ErbB2 is constitutively endocytosed and subsequently degraded in lysosomes.
    Vuong TT; Berger C; Bertelsen V; Rødland MS; Stang E; Madshus IH
    Exp Cell Res; 2013 Feb; 319(3):32-45. PubMed ID: 23127513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an HSP90 modulated multi-step process for ERBB2 degradation in breast cancer cells.
    Castagnola P; Bellese G; Birocchi F; Gagliani MC; Tacchetti C; Cortese K
    Oncotarget; 2016 Dec; 7(51):85411-85429. PubMed ID: 27863425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geldanamycin stimulates internalization of ErbB2 in a proteasome-dependent way.
    Lerdrup M; Hommelgaard AM; Grandal M; van Deurs B
    J Cell Sci; 2006 Jan; 119(Pt 1):85-95. PubMed ID: 16352662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geldanamycin-induced down-regulation of ErbB2 from the plasma membrane is clathrin dependent but proteasomal activity independent.
    Pedersen NM; Madshus IH; Haslekås C; Stang E
    Mol Cancer Res; 2008 Mar; 6(3):491-500. PubMed ID: 18337455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer.
    Zhang J; Liu S; Li Q; Shi Y; Wu Y; Liu F; Wang S; Zaky MY; Yousuf W; Sun Q; Guo D; Wang T; Zhang Y; Wang Y; Li M; Liu H
    Cell Death Differ; 2020 Sep; 27(9):2710-2725. PubMed ID: 32327714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clathrin-independent endocytosis of ErbB2 in geldanamycin-treated human breast cancer cells.
    Barr DJ; Ostermeyer-Fay AG; Matundan RA; Brown DA
    J Cell Sci; 2008 Oct; 121(Pt 19):3155-66. PubMed ID: 18765569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocytosis and sorting of ErbB2 and the site of action of cancer therapeutics trastuzumab and geldanamycin.
    Austin CD; De Mazière AM; Pisacane PI; van Dijk SM; Eigenbrot C; Sliwkowski MX; Klumperman J; Scheller RH
    Mol Biol Cell; 2004 Dec; 15(12):5268-82. PubMed ID: 15385631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HSP90 inhibitor geldanamycin perturbs endosomal structure and drives recycling ErbB2 and transferrin to modified MVBs/lysosomal compartments.
    Cortese K; Howes MT; Lundmark R; Tagliatti E; Bagnato P; Petrelli A; Bono M; McMahon HT; Parton RG; Tacchetti C
    Mol Biol Cell; 2013 Jan; 24(2):129-44. PubMed ID: 23154999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
    Pedersen NM; Breen K; Rødland MS; Haslekås C; Stang E; Madshus IH
    Mol Cancer Res; 2009 Feb; 7(2):275-84. PubMed ID: 19208749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ErbB2 trafficking and degradation associated with K48 and K63 polyubiquitination.
    Marx C; Held JM; Gibson BW; Benz CC
    Cancer Res; 2010 May; 70(9):3709-17. PubMed ID: 20406983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase C mediated internalization of ErbB2 is independent of clathrin, ubiquitination and Hsp90 dissociation.
    Dietrich M; Malik MS; Nikolaysen F; Skeie M; Stang E
    Exp Cell Res; 2018 Oct; 371(1):139-150. PubMed ID: 30098331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A kinase inhibitor screen reveals protein kinase C-dependent endocytic recycling of ErbB2 in breast cancer cells.
    Bailey TA; Luan H; Tom E; Bielecki TA; Mohapatra B; Ahmad G; George M; Kelly DL; Natarajan A; Raja SM; Band V; Band H
    J Biol Chem; 2014 Oct; 289(44):30443-30458. PubMed ID: 25225290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neratinib induces ErbB2 ubiquitylation and endocytic degradation via HSP90 dissociation in breast cancer cells.
    Zhang Y; Zhang J; Liu C; Du S; Feng L; Luan X; Zhang Y; Shi Y; Wang T; Wu Y; Cheng W; Meng S; Li M; Liu H
    Cancer Lett; 2016 Nov; 382(2):176-185. PubMed ID: 27597738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoplasmic reticulum vacuolization and valosin-containing protein relocalization result from simultaneous hsp90 inhibition by geldanamycin and proteasome inhibition by velcade.
    Mimnaugh EG; Xu W; Vos M; Yuan X; Neckers L
    Mol Cancer Res; 2006 Sep; 4(9):667-81. PubMed ID: 16966435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flotillin depletion affects ErbB protein levels in different human breast cancer cells.
    Asp N; Pust S; Sandvig K
    Biochim Biophys Acta; 2014 Sep; 1843(9):1987-96. PubMed ID: 24747692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the domain in ErbB2 that restricts ligand-induced degradation.
    Shen F; Lin Q; Childress C; Yang W
    Cell Signal; 2008 Apr; 20(4):779-86. PubMed ID: 18255265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visualization of Rab5 activity in living cells by FRET microscopy and influence of plasma-membrane-targeted Rab5 on clathrin-dependent endocytosis.
    Galperin E; Sorkin A
    J Cell Sci; 2003 Dec; 116(Pt 23):4799-810. PubMed ID: 14600265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.
    Bonvini P; An WG; Rosolen A; Nguyen P; Trepel J; Garcia de Herreros A; Dunach M; Neckers LM
    Cancer Res; 2001 Feb; 61(4):1671-7. PubMed ID: 11245482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct regulation of insulin receptor substrate-1 and -2 by 90-kDa heat-shock protein in adrenal chromaffin cells.
    Yoshikawa N; Nemoto T; Satoh S; Maruta T; Yanagita T; Chosa E; Wada A
    Neurochem Int; 2010 Jan; 56(1):42-50. PubMed ID: 19737590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.